Skip to main content
. 2021 May 19;13(2):162–168. doi: 10.34172/jcvtr.2021.31

Table 3. Outcome indicators at 2 year follow up.

Cumulative Results at 2 Year follow-up Overall (2493) N (%) DM (854) N (%) Non-DM (1639) N (%) P value
Lost to follow up 7 (0.28) 5 (0.58) 2 (0.12) 0.038
3-P MACE 79 (3.16) 40 (4.7) 39 (2.4) 0.002
Cardiac-Death 34 (1.36) 18 (2.1) 16 (1) 0.034
TV-MI 9 (0.36) 4 (0.5) 5 (0.3) 0.774
TLR/TVR 36 (1.44) 18 (2.1) 18 (1.1) 0.069
Total Stent Thrombosis 14 (0.56) 7 (0.8) 7 (0.4) 0.34
Definite 10 (0.4) 5 (0.6) 5 (0.3) 0.477
Acute stent thrombosis 2 (0.08) 1 (0.1) 1 (0.1) 0.78
Sub-acute stent thrombosis 8 (0.32) 4 (0.5) 4 (0.2) 0.575
Late stent thrombosis 0 (0) 0 (0) 0 (0)  -
Probable 4 (0.16) 2 (0.2) 2 (0.1) 0.894
Acute stent thrombosis 4 (0.16) 2 (0.2) 2 (0.1) 0.894
Sub-acute stent thrombosis 0 (0) 0 (0) 0 (0)  -

Abbreviations: TLR/TVR, target lesion/vessel revascularization; DM, diabetes mellitus; MACE, major adverse cardiovascular events; ST, stent thrombosis; TV-MI, target vessel myocardial infarction

Pvalues refer to the two subgroups.